Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
Recruiting
Observational Study
Breast Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 100
- Sex
- Female
- Study type
- Observational
- Participants needed
- 4,500 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female patients, ages 18 to 100 years
* Had a benign breast biopsy at Mayo Clinic between 2002-2022
Exclusion Criteria:
* All male patients
* Prior or concomitant diagnosis of BC
* Diagnosis of BC within six months of benign breast disease
* Denial of research authorization
…
Contacts